Implantation or Injectable Dosage Form New Animal Drugs; Beta- Aminopropionitrile Fumarate

Özet

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Alaco, Inc. The NADA provides for veterinary prescription use of beta-aminopropionitrile fumarate by injection for intratendinous treatment of superficial digital flexor tendinitis of horses.